NSEESOP/ESOS/ESPS11 Sept 2026 · 11 Sept 2026, 04:34 pm

ESOP/ESOS/ESPS

Emcure Pharmaceuticals Limited · EMCURE

✦ AI SummaryESOP/ESOS/ESPS

Emcure Pharmaceuticals Limited has informed the Exchange regarding the allotment of 11,400 shares to eligible employees under the Emcure - Employee Stock Option Scheme 2013. The issued and paid-up share capital of the Company has increased to 18,97,10,647 Equity Shares of Rs. 10/- each, aggregating to Rs. 1,89,71,06,470/-.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Emcure Pharmaceuticals Limited has informed the Exchange regarding Allotment of 11400 Shares.

Attachments (1)

📄

EMCURE_11092026163435_EPLIntimationAllotmentofEquityShares.pdf

pdf

Download →
View document text
Emcure Ref: EPL/CS/SE/0081/2026 Date: September 11, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure - Employee Stock Option Scheme 2013. Pursuant to Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform that the Nomination and Remuneration Committee of the Board of Directors of the Company, vide its Resolution by Circulation (No. 04 of 2026-27) passed on September 11, 2026, has approved allotment of 11,400 (Eleven Thousand Four Hundred) Equity Shares of Rs. 10/- (Rupees Ten only) each of the Company to the eligible employees, pursuant to Emcure - Employee Stock Option Scheme 2013 (“Emcure ESOS 2013”), upon exercise of 11,400 vested options. Further, consequent to the aforesaid allotment, the issued and paid-up share capital of the Company stands increased as under: From To 18,96,99,247 Equity Shares of Rs. 10/- each 18,97,10,647 Equity Shares of Rs. 10/- each aggregating to Rs. 1,89,69,92,470/- aggregating to Rs. 1,89,71,06,470/- The aforesaid Equity Shares shall rank pari passu in all aspects with the existing Equity Shares of the Company. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary and Compliance Officer Membership No.: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251